Infliximab
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19603 publications
Utility of tolerance assays for real-time management of infliximab infusion reactions.
Journal: Revista espanola de enfermedades digestivas
Published: January 22, 2026
Tribulations of Randomized Controlled Trials: Testing the Inflammatory Hypothesis of Heart Failure.
Journal: Circulation. Heart failure
Published: January 22, 2026
A 17-Year-Old Male Adolescent With Refractory Crohn's Disease Managed With Upadacitinib and Risankizumab Combination Therapy: A Case Report and Review of Current Evidence.
Journal: The American journal of case reports
Published: January 16, 2026
Out-of-Pocket Spending for Biologic Drugs After Biosimilar Competition for Medicare Patients.
Journal: JAMA network open
Published: January 15, 2026
Unusual presentation of Crohn disease associated with hemophagocytic lymphohistiocytosis syndrome: a case report
Journal: Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru
Published: January 13, 2026
Efficacy of intravenous infliximab in axial spondyloarthritis: impact on disease activity, quality of life, and productivity in subgroups with psoriasis and inflammatory bowel disease.
Journal: Expert opinion on biological therapy
Published: January 13, 2026
Epstein-Barr virus colitis on a background of Crohn's disease.
Journal: BMJ case reports
Published: January 09, 2026
Mirikizumab effectiveness in a pregnant woman with acute severe ulcerative colitis: a case report.
Journal: Minerva gastroenterology
Published: January 09, 2026
Chronic Watery Diarrhea With Colonic Intraepithelial Lymphocytosis Refractory To Budesonide Treatment - A Case Report.
Journal: Zeitschrift fur Gastroenterologie
Published: January 08, 2026
Development and validation of a novel clinical decision support tool for sustained remission in Crohn's disease: a multi-center real-world study.
Journal: Scandinavian journal of gastroenterology
Published: January 02, 2026
Rationale and design of the AlloFIST trial: a phase I/IIa study to evaluate dose escalation of allogeneic adipose-derived stroma/stem cells for the treatment of Crohn's fistula.
Journal: BMJ open
Published: December 30, 2025
Last Updated: 02/24/2026